Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.39M | 7.37M | 6.28M | 4.82M | 2.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.39M | 7.37M | 6.28M | 4.82M | 2.27M |
| Cost of Revenue | 55.13M | 60.71M | 62.54M | 58.46M | 52.31M |
| Gross Profit | -48.74M | -53.34M | -56.25M | -53.64M | -50.04M |
| SG&A Expenses | 38.60M | 41.16M | 42.30M | 41.84M | 41.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.73M | 101.87M | 104.84M | 100.30M | 94.18M |
| Operating Income | -87.34M | -94.50M | -98.55M | -95.48M | -91.91M |
| Income Before Tax | -116.62M | -88.31M | -91.26M | -87.29M | -83.44M |
| Income Tax Expenses | 637.00K | 104.00K | 95.00K | 124.00K | 141.00K |
| Earnings from Continuing Operations | -117.26 | -88.42 | -91.36 | -87.41 | -83.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.26M | -88.42M | -91.36M | -87.41M | -83.58M |
| EBIT | -87.34M | -94.50M | -98.55M | -95.48M | -91.91M |
| EBITDA | -83.06M | -89.62M | -93.98M | -91.41M | -88.35M |
| EPS Basic | -12.47 | -9.42 | -9.76 | -9.44 | -9.39 |
| Normalized Basic EPS | -5.46 | -5.88 | -6.09 | -5.89 | -5.86 |
| EPS Diluted | -12.47 | -9.42 | -9.76 | -9.44 | -9.39 |
| Normalized Diluted EPS | -5.46 | -5.88 | -6.09 | -5.89 | -5.86 |
| Average Basic Shares Outstanding | 37.58M | 37.53M | 37.45M | 37.04M | 35.68M |
| Average Diluted Shares Outstanding | 37.58M | 37.53M | 37.45M | 37.04M | 35.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |